An amoeba to help the eco-industry
Willaertia magna C2c MakyAmoéba develops applications by exploiting the characteristics of the amoeba Willaertia magna C2c Maky. This amoeba has been isolated from the environment and has natural properties.
Lastest news
28 August 2024
AMOEBA prepares for the commercial launch of the AXPERA Product Line in the USA with approval expected by 2025
Amoéba, an industrial greentech specialising in the development of natural microbiological solutions based on the patented use of amoebae, announces that the US Environmental Protection Agency (US EPA) has confirmed the admissibility and completeness of the registration dossier for its biocontrol products in the United States.
2 July 2024
A new legal structure to maximise commercial activities
Amoéba , an industrial greentech specialising in the treatment of microbiological risk, announces a major legal reorganisation designed to strengthen the development of its commercial activities in the biocontrol and cosmetics sectors, and to create value for its shareholders.
10 June 2024
Confirmation of the development potential of Amoeba in cosmetics
Amoeba, an industrial greentech specialised in the treatment of microbiological risk, developing a biocontrol agent for the protection of plants in agriculture and a range of cosmetic ingredients, announces that it has received the results of the clinical study confirming the interest of using its ingredient in cosmetic as a skin care product.
2 May 2024
Amoéba’s Board of Directors renewed to support the company’s new strategic ambitions
Amoéba, an industrial biotech specialised in the treatment of microbiological risk, developing a biocontrol agent for the protection of plants in agriculture and a range of anti-ageing cosmetic ingredients, is appointing a new Board of Directors, welcoming four well-known figures specialised in the fields that represent the company’s core activities.
Business
At the crossroads of environmental protection and public health issues, we are developing a three-fold scientific, industrial and commercial expertise. The company is developing around multiple applications using the amoeba Willaertia magna C2c Maky in the prevention of microbiological risk for water treatment, human wounds and plant protection.
DiscoverBiocide
The only biological biocide that can be used in air cooling towers, with no hazard class for human health and the environment.Water treatment
Our disruptive biocide helps control the level of Legionella, both those present in the water and those colonizing the biofilm.
The effectiveness of the biocide is due to the natural properties of the amoeba Willaertia magna C2c Maky, which predates pathogenic bacteria and other free-standing amoebae.
For the first time in 50 years of industrial water treatment, Amoéba is giving industry the opportunity to choose a responsible alternative.
Learn moreTestimonials
The industry professionals testify about their experiences with the biological biocide BIOMEBA.Dalkia
Vitacuire
Häagen Dazs
Research & Development
Other research is currently being conducted in order to make the best use of Willaertia magna C2c Maky’s different properties.
These properties open up a wide range of applications, particularly at the interface between health and environment fields.
All about it